NCT04616625View on ClinicalTrials.gov

Cardiovascular Effects of Prenatal Methamphetamine Exposure

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Methamphetamine AbuseNewborn Complication | Patient | Neonatalology
Trial Locations (2)

95817

UC Davis Children's Hospital, Sacramento

95901

Adventist Health and Rideout, Marysville

All Listed Sponsors
collaborator

Adventist Health and Rideout

UNKNOWN

lead

University of California, Davis

OTHER

NCT04616625 - Cardiovascular Effects of Prenatal Methamphetamine Exposure | Biotech Hunter | Biotech Hunter